Sarah Gheuens – Biography
Last update: January 30, 2026Executive profile
Sarah was Executive Medical Director and Head of Multiple Sclerosis, Late Stage Clinical Development for Biogen. Sarah served as Interim Head of Regulatory Affairs and Chief Medical Officer and Executive Vice President for Sagard Holdings.
Sarah Gheuens is currentlyHead of Research & Development and Chief Medical Officer at Agios Pharmaceuticals - View - Agios Pharmaceuticals org chart
Director at Viridian Therapeutics - View - Viridian Therapeutics org chart
Create your alert
to follow the career of Sarah Gheuens.
Education
Sarah Gheuens has a Doctor of Medicine from Vrije Universiteit Brussel and a Master in Medical Science from Harvard Medical School.
They have also studied at Vrije Universiteit Brussel :
Find more alumni from Vrije Universiteit Brussel
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
More about Sarah Gheuens
Selected links
Do you need to know more about Sarah Gheuens? More results.
Participate
Social media
- Sarah Gheuens on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Sarah Gheuens
The colleagues of Sarah Gheuens
Company Colleagues
- At Agios Pharmaceuticals, Sarah Gheuens has 20 colleagues including Brian Goff (CEO & Director), Maykin Ho (Director)…
- At Viridian Therapeutics, Sarah Gheuens has 24 colleagues including Stephen Mahoney (CEO & Director), Arlene Morris (Director)…
Industry Colleagues
- In the Pharmaceuticals industry, Sarah Gheuens has 22,996 colleagues in 1,914 companies located in 68 countries. 10,821 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Sarah Gheuens.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Sarah Gheuens.
